Clinical Trials
45 trialsDAPPER
Mayo Clinic
TRAP
Royal Marsden NHS Foundation Trust
STEREOBED
Jules Bordet Institute
ORION
Center Eugene Marquis
MRI-guided Locoregional SBRT Prostate Program
Clinica Universidad de Navarra, Universidad de Navarra
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
M.D. Anderson Cancer Center
Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer
Mayo Clinic
SBRT Boost for Unfavorable Prostate Cancer'
MemorialCare Health System
PROSTERA
Clinique Sainte Clotilde
GARUDA
Jonsson Comprehensive Cancer Center
Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer
Jonsson Comprehensive Cancer Center
DE-CART
Fox Chase Cancer Center
Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer
Hoag Memorial Hospital Presbyterian
TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer
MemorialCare Health System
HYDRA
Jonsson Comprehensive Cancer Center
Hypofractionated Stereotactic Body Radiation Therapy as a Boost to the Prostate
Boston Medical Center
Single Fractions SBRT for Prostate Cancer
McGill University Health Centre/Research Institute of the McGill University Health Centre
PLUTO-MPC
Sunnybrook Health Sciences Centre
Rectal Spacer Hydrogel Before Radiation Therapy in Reducing Radiation Dose to the Rectum in Patients With Prostate Cancer
Icahn School of Medicine at Mount Sinai
Stereotactic Radiotherapy of Prostate Cancer With Reduction of Safety Margins
University Hospital Ostrava
CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer
Wake Forest University Health Sciences
Adaptive MR-guided SBRT for Localized Prostate Cancer
University of Zurich
Magnetic Resonance Guided Focal Stereotactic Body Radiation Therapy for Localized Prostate Cancer
Case Comprehensive Cancer Center
Hypofractionated SBRT For Prostate Cancer
University of Pittsburgh
HypoF-SBRT
University Hospital Freiburg
CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry
Accuray Incorporated
CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution
Accuray Incorporated
Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer (RAD 1203)
University of Alabama at Birmingham
Hypofractionated Stereotactic Body Radiation Therapy for Patients With Prostate Cancer That Was Removed by Surgery
University of Southern California
5STAR-PC
Sunnybrook Health Sciences Centre
Radiotherapy for Oligometastatic Prostate Cancer
University of Florida
A Phase II Clinical Study of Stereotactic Radiation Therapy in Patients With High-risk Prostate Cancer
West China Hospital
SMART
Duke University
Phase II Study of SBRT as Treatment for Oligometastases in Prostate Cancer
Grupo de Investigación Clínica en Oncología Radioterapia
eHYPO
Regina Elena Cancer Institute
Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate Cancer
Jonsson Comprehensive Cancer Center
SBRT
Changhai Hospital
Stereotactic Body Radiotherapy for Prostate Cancer
Mercy Research
Single Arm Trial of Preoperative Stereotactic Body Radiation Therapy (SBRT) for T3a or Gleason Grade Group 4 Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute
High-Dose Stereotactic Radiation for Prostate Cancer
Case Comprehensive Cancer Center
Stereotactic Body Radiation Therapy in Treating Patients With Low- and Intermediate-Risk Prostate Cancer
Virginia Commonwealth University
Stereotactic Radiation Therapy in Treating Patients With Prostate Cancer
Case Comprehensive Cancer Center
A Phase II Trial of CyberKnife Stereotactic Radiosurgery to Prostate Tumors
Community Cancer Center, Normal, Illinois
Stereotactic Body Radiotherapy for Stage I-III Prostate Cancer
Swedish Medical Center
Endoscopic Evaluation of Late Rectal Injury Following CyberKnife Radiosurgery for Prostate Cancer
Georgetown University